Literature DB >> 11132246

High glucose enhances IL-1beta-induced cyclooxygenase-2 expression in rat vascular smooth muscle cells.

S H Lee1, H G Woo, E J Baik, C H Moon.   

Abstract

The changes in vascular prostaglandin production are implicated in the derangement of vascular reactivity in diabetes. However, the mechanism of altered prostaglandin (PG) production in diabetes is largely unknown. In this study, we investigated the effect of high glucose on IL-1beta-induced PG production and the possible underlying mechanism in cultured vascular smooth muscle cell (VSMC). High glucose evoked an augmentation of IL-1beta-induced PG synthesis in a dose dependent manner and enhanced cyclooxygenase (COX) activity, which reached to maximum at 8-12 hours after stimulation. Western blot analysis supported the activity data. Protein kinase C (PKC) inhibitors, H-7 and chelerythrine, significantly inhibited the enhancement of IL-1beta-induced COX-2 expression by high glucose. The activation of PKC by PMA resulted in marked increase of PG production in low glucose group, whilst this was not the case in high glucose group. Furthermore, glucose-enhancing effect was significantly suppressed by zopolrestat, an aldose reductase inhibitor, and sodium pyruvate. These results suggest that the augmenting effect of high glucose on IL-1beta-induced PG production and COX-2 expression is, at least in part, due to increased glucose metabolism via sorbitol pathway following PKC activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11132246     DOI: 10.1016/s0024-3205(00)00920-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Protective effect of rhIL-1beta on pancreatic islets of alloxan-induced diabetic rats.

Authors:  Li-Ping Wu; Li-Hua Chen; Jin-Shan Zhang; Lan Sun; Yuan-Qiang Zhang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

2.  Cyclooxygenase-2 (PTGS2) inhibitors augment the rate of hexose transport in L6 myotubes in an insulin- and AMPKalpha-independent manner.

Authors:  E Alpert; A Gruzman; B Lardi-Studler; G Cohen; R Reich; S Sasson
Journal:  Diabetologia       Date:  2006-01-31       Impact factor: 10.122

3.  Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products.

Authors:  Narkunaraja Shanmugam; Marpadga A Reddy; Rama Natarajan
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

4.  Reduction of lipopolysaccharide-induced cyclooxygenase-2 expression in diabetic arteries.

Authors:  Yuji Takahashi; Michael Poteser; Munetaka Negoro; Ichiro Wakabayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-20       Impact factor: 3.000

5.  Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats.

Authors:  Y Shi; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

6.  Linking Chronic Inflammation with Cardiovascular Disease: From Normal Aging to the Metabolic Syndrome.

Authors:  Angel Lopez-Candales; Paula M Hernández Burgos; Dagmar F Hernandez-Suarez; David Harris
Journal:  J Nat Sci       Date:  2017-04

7.  Vitamin K1 prevents diabetic cataract by inhibiting lens aldose reductase 2 (ALR2) activity.

Authors:  R Thiagarajan; M K N Sai Varsha; V Srinivasan; R Ravichandran; K Saraboji
Journal:  Sci Rep       Date:  2019-10-11       Impact factor: 4.379

8.  Relationship between serum levels of triglycerides and vascular inflammation, measured as COX-2, in arteries from diabetic patients: a translational study.

Authors:  Antonio Gordillo-Moscoso; Emilio Ruiz; Manuel Carnero; Fernando Reguillo; Enrique Rodriguez; Teresa Tejerina; Santiago Redondo
Journal:  Lipids Health Dis       Date:  2013-05-03       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.